Comment on 'Development of eruptive pseudoangiomatosis following COVID-19 inmunization-apropos of 5 cases': could eruptive pseudoangiomatosis represent a paraviral eruption associated with SARS-CoV-2?

Moya-Martinez, C; Berná-Rico, E D; Melian-Olivera, A; Moreno-Garcia Del Real, C; Fernández-Nieto, D

Moya-Martinez, C; Berná-Rico, E D; Melian-Olivera, A; Moreno-Garcia Del Real, C; Fernández-Nieto, D.

Moya-Martinez C; Dermatology Department, Hospital Universitario Fundación Jimenez Diaz, Madrid, Spain.
Berná-Rico ED; Dermatology Department, Hospital Universitario Ramón y Cajal, IRYCIS, Madrid, Spain.
Melian-Olivera A; Dermatology Department, Hospital Universitario Ramón y Cajal, IRYCIS, Madrid, Spain.
Moreno-Garcia Del Real C; Pathology Department, Hospital Universitario Ramón y Cajal, IRYCIS, Madrid, Spain.
Fernández-Nieto D; Dermatology Department, Hospital Universitario Ramón y Cajal, IRYCIS, Madrid, Spain.

J Eur Acad Dermatol Venereol ; 36(2): e95-e97, 2022 02.

Article in English | MEDLINE | ID: covidwho-1470441

Subject(s)

COVID-19; Exanthema; Diagnostic Tests, Routine; Humans; SARS-CoV-2

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Exanthema / COVID-19 Type of study: Diagnostic study Limits: Humans Language: English Journal: J Eur Acad Dermatol Venereol Journal subject: Dermatology / Sexually Transmitted Diseases Year: 2022 Document Type: Article Affiliation country: Jdv.17750

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google